Increasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A.
The gravimetric uterotrophic assay is currently the most well-established, short-term rodent estrogenicity assay. Increasing attention is being paid to the extent to which use of morphometric or molecular changes in the uterus could act as surrogates for the gravimetric end point of the assay, thereby perhaps increasing the sensitivity of the assay. In this paper I discuss the available data, paying particular attention to studies on bisphenol A (BPA) because it offers the largest database for consideration. I conclude that the case has yet to be made for augmenting the gravimetric end point of the uterotrophic assay. To resolve this important question, it will be necessary to conduct detailed dose-response studies where the no-observed-effect level (NOEL) for the proposed surrogate end points are compared with the NOEL for the gravimetric end point. Currently, few such studies exist, and among those that do no clear message emerges. The general trend to increasing use of molecular assays in toxicology (multigene microarrays and real-time polymerase chain reaction) emphasizes the need for clear criteria for comparing the performance of individual markers of toxicity.
Ashby
J
J
Syngenta Central Toxicology Laboratory, Macclesfield, Cheshire, UK. John.Ashby@Syngenta.com
D000818:Animals; D001559:Benzhydryl Compounds; D001681:Biological Assay; D016208:Databases, Factual; D004968:Estrogens, Non-Steroidal / Q000009:adverse effects*; D005260:Female; D051379:Mice; D019055:No-Observed-Adverse-Effect Level; D010636:Phenols / Q000009:adverse effects*; D051381:Rats; D012680:Sensitivity and Specificity; D018675:Toxicity Tests / Q000379:methods / Q000592:standards; D014599:Uterus / Q000166:cytology* / Q000187:drug effects* / Q000473:pathology; D000098826:Bisphenol A Compounds
D001559:Benzhydryl Compounds; D004968:Estrogens, Non-Steroidal; D010636:Phenols; C006780:bisphenol A; D000098826:Bisphenol A Compounds